KAYLA JOHNSON: Open Payments
NPI 1164045746 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 10 payments from 7 companies in 2025. Trend: 2023 $414 · 2024 $0 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| ARGENX US, INC. | 2 | $50 |
| Alexion Pharmaceuticals, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $49 |
| Boston Scientific Corporation | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: SAPHNELO, VYVGART HYTRULO, JARDIANCE, WaveWriter Alpha Prime 16, ULTOMIRIS, Wegovy, ZEPBOUND, ENTYVIO.
Industry payments across NC — which companies pay providers there.
